On January 2, Rahul Khara, the chief legal officer of Disc Medicine (NASDAQ:IRON), exercised and sold 6,500 shares in a derivative transaction valued at approximately $511,472, as reported in an SEC Form 4 filing. The transaction’s value is based on the SEC Form 4’s weighted average purchase price, with the post-transaction value reflecting the market close on January 2. The price change over the year is calculated using January 2, 2026, as the reference date.
Want More Context? 🔎
